Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
활용도 Analysis
논문 Analysis
연구자 Analysis
'
Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease' 의 참고문헌
Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization of Crohn’s and Colitis (AOCC) meeting in Seoul
The prevalence and clinical characteristics of anemia in Korean patients with inflammatory bowel disease
The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates
Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis
Prevalence of occult hepatitis B virus infection in a general adult population in Korea
Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients
Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey
Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France
Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-alpha agents
Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study
Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease
Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses
Occult hepatitis B and infliximab-induced HBV reactivation
Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs
Interleukin 12 and Th1 responses in inflammatory bowel disease
Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases
Immunogenicity of hepatitis B Vaccines: implications for persons at occupational risk of hepatitis B virus infection
Immunogenicity of combined hepatitis A and B vaccine in elderly persons
High prevalence of antihepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan
Hepatitis B virus reactivation and alemtuzumab therapy
Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementino Fraga Filho University Hospital
Hepatitis B virus infection
Hepatitis B vaccine by intradermal route in non responder patients: an update
Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab
Hepatitis B and C virus infection in Crohn's disease
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations
Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study
Epidemiology and prevention of hepatitis B virus infection
Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases
Adequate rate of response to hepatitis B virus vaccination in patients with inflammatory bowel disease
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn’s disease
'
Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease'
의 유사주제(
